ESR2 and adenoma: The protective mechanism of estrogen in the adenoma to carcinoma sequence was investigated using ApcMin/+ mice models, which simulate the hereditary CRC pathway: male and female mice treated with an exogenous ERβ selective agonist exhibited a significant reduction in small-intestinal polyp number (39%) and diameter (36%) [62].